Welcome to our dedicated page for DOCUSIGN SEC filings (Ticker: DOCU), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on DOCUSIGN's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into DOCUSIGN's regulatory disclosures and financial reporting.
DocuSign, Inc. (DOCU) filed a Form 144 disclosing that the Daniel Springer Revocable Trust, identified as a former affiliate, plans to sell up to 66,882 common shares on or about 26 June 2025. The shares will be sold through Morgan Stanley Smith Barney LLC on the Nasdaq exchange. At the 4 June 2025 market price implied by the filing, the transaction represents an aggregate market value of approximately US$5.04 million, equating to an implied price of roughly US$75.31 per share.
The proposed sale represents less than 0.04 % of DocuSign’s 202,062,772 shares outstanding, indicating limited dilution or market overhang risk. The securities were originally acquired via open-market purchase on 15 March 2022 and were fully paid for in cash. The filer reported no other sales in the past three months and affirmed that no undisclosed material adverse information is known.
Form 144 filings are routinely used by insiders and affiliates to notify the SEC of intended Rule 144 sales and do not obligate the seller to complete the transaction. Nevertheless, investors often monitor such filings as indicators of insider sentiment, even when the dollar amount is modest relative to the company’s market capitalization.